September 2010

Now That's What I Call a Drug That Works (Seattle Genetics)
Now That's What I Call a Drug That Works (Seattle Genetics)
Motley Fool
Seattle Genetics
brentuximab vedotin
Hodgkin's lymphoma
Pfizer Inc. (NYSE:PFE) – Q3 2010 Earnings Preview
Pfizer Inc. (NYSE:PFE) – Q3 2010 Earnings Preview
iStockAnalyst
Pfizer
earnings
Will Johnson & Johnson Blow It Next Quarter?
Will Johnson & Johnson Blow It Next Quarter?
Motley Fool
JNJ
earnings
Actelion's Experimental Drug for Brain Hemorrhage Fails to Meet Study Goal
Actelion's Experimental Drug for Brain Hemorrhage Fails to Meet Study Goal
Bloomberg
Actelion
brain hemorrhage
clazosentan
Allergan, Hologic Pass FDA Checkpoints
Allergan, Hologic Pass FDA Checkpoints
Forbes
Hologic
FDA
Allergan
Ozurdex
Pfizer halts study of Sutent for prostate cancer
Pfizer halts study of Sutent for prostate cancer
Marketwatch
Sutent
prostate cancer
Pfizer
Better Buy: Ariad Pharmaceuticals or Corcept Therapeutics?
Better Buy: Ariad Pharmaceuticals or Corcept Therapeutics?
Motley Fool
Ariad Pharmaceuticals
Corcept Therapeutics
ridaforolimus
Merck
Cushing's disease
Corlux
Novartis
Pfizer Sues Novo Nordisk in London Court Over Patent on Insulin Device
Pfizer Sues Novo Nordisk in London Court Over Patent on Insulin Device
Bloomberg
Pfizer
Novo Nordisk
lawsuits
diabetes
Pfizer plans more partnerships in Asia
Pfizer plans more partnerships in Asia
Outsourcing Pharma
Pfizer
Asia
partnerships
CROs
Centocor seeks expansion of Simponi use
Centocor seeks expansion of Simponi use
Bizjournals.com
Janssen Biotech
Simponi
rheumatoid arthritis

Pages